NCT07023640View on ClinicalTrials.gov

Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

June 17, 2026

Study Completion Date

June 17, 2026

Conditions
Malignant Neoplasms of Brain
Interventions
DIAGNOSTIC_TEST

68Ga-DOTA-mPNE

PET/CT examination was performed after intravenous injection of 68GA-DOTA-mPNE tracer

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT07023640 - Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors | Biotech Hunter | Biotech Hunter